Brian Armstrong is conquering challenges - from cryptocurrency regulations to extending human lifespan. While most CEOs in the cryptocurrency industry are struggling with market volatility, Armstrong is busy with larger strategies: fighting aging and Washington regulations simultaneously.
NewLimit Raises 130 Million USD to Restructure Human Lifespan
The NewLimit project co-founded by Armstrong has just completed its Series B capital raise with 130 million USD. The company is developing a therapy to restore the youthful function of aging cells through genetic reprogramming. Initial results are quite optimistic, as they have developed three experimental drugs targeting liver cells. Armstrong emphasizes the urgency of addressing the "greatest tragedy" - aging.
Anti-Aging Battle: Technology Giants Join Forces!
Armstrong is not alone in this mission, collaborating with tech titans like Jeff Bezos and Vitalik Buterin. However, Armstrong's approach combines science and management, always staying one step ahead.
Fighting for Stablecoin Regulations
Coinbase's CEO continuously advocates for cryptocurrency regulations. Recently, he called on the US Senate to discuss the GENIUS Act, a bill regulating stablecoins. This bill could create a federal licensing regime and a dual oversight model. The Treasury Department predicts stablecoins could increase from 230 billion USD to 2,000 billion USD by 2028, creating opportunities and risks for the traditional banking system.
Brian Armstrong is betting on the future, and he is doing so from all angles.
